4.6 Article

PET imaging in animal models of Parkinson's disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Radiology, Nuclear Medicine & Medical Imaging

Tracking Innate Immune Activation in a Mouse Model of Parkinson's Disease Using TREM1 and TSPO PET Tracers

Katherine L. Lucot et al.

Summary: This study investigated the usefulness of TSPO and TREM1 PET tracers in detecting innate immune responses in a mouse model of Parkinson's disease. The results showed that these tracers have the potential to detect activated microglia and peripheral myeloid cells, and can be used to assess immune responses associated with dopaminergic neuron degeneration.

JOURNAL OF NUCLEAR MEDICINE (2022)

Review Clinical Neurology

Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches

Nicolaas I. Bohnen et al.

Summary: In patients with Parkinson's disease, heterogeneous cholinergic system changes can occur in different brain regions, affecting various clinical features and neural circuitries. Cholinergic deficits within cognition network hubs are better predictors of cognitive deficits. The topographies of cholinergic changes overlap with neural circuitries involved in sleep, cognition, motor function, sensory perception, and autonomic functions.

LANCET NEUROLOGY (2022)

Review Geriatrics & Gerontology

Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia

Ruiqing Ni et al.

Summary: Early detection and intervention for dementia are important unmet clinical needs. Neurodegenerative diseases causing dementia are characterized by abnormal accumulation and spreading of pathological protein aggregates. Advances in PET biomarkers have improved understanding of disease mechanisms and development of therapeutics. Inclusion of biomarkers in diagnostic criteria has facilitated early diagnosis and impacted clinical management.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Article Clinical Neurology

Dopaminergic Positron Emission Tomography Imaging in the Alpha-Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease

Vesna Sossi et al.

Summary: The study investigated dopaminergic deficits in a rat model and found that there were progressive decreases in DAT density and increases in DA turnover, which resemble the alterations observed in human PD.

MOVEMENT DISORDERS (2022)

Article Neurosciences

Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism

Francisco Molinet-Dronda et al.

Summary: Dopaminergic denervation in patients with Parkinson's disease causes changes in brain metabolism. This study investigated the metabolic changes in the brains of monkeys in the early stages of dopaminergic depletion. The findings suggest that early dopaminergic depletion is associated with cortical hypometabolism, which is unrelated to neuron loss.

NEUROBIOLOGY OF DISEASE (2022)

Article Neurosciences

In vivo imaging of alpha-synuclein with antibody-based PET

Sahar Roshanbin et al.

Summary: By utilizing bispecific antibodies for PET imaging, alpha SYN was successfully visualized in the mouse brain, showing potential application in synucleinopathies. However, challenges remain in imaging intracellular alpha SYN inclusions.

NEUROPHARMACOLOGY (2022)

Article Neurosciences

Pathophysiological significance of increased α-synuclein deposition in sympathetic nerves in Parkinson's disease: a post-mortem observational study

Risa Isonaka et al.

Summary: Parkinson's disease is associated with increased alpha-synuclein deposition in the skin, submandibular gland, and myocardial tissues. This deposition does not seem to be pathogenic in the skin and submandibular gland, but it is highly significant in the heart.

TRANSLATIONAL NEURODEGENERATION (2022)

Review Medicine, General & Internal

Recent Technical Advances in Accelerating the Clinical Translation of Small Animal Brain Imaging: Hybrid Imaging, Deep Learning, and Transcriptomics

Wuwei Ren et al.

Summary: Small animal models are crucial in brain research to deepen the understanding and develop therapeutic and diagnostic imaging tracers. However, there are still barriers in translating this research to the clinical setting. Technical improvements, such as hybrid imaging and deep learning-based analysis, can help overcome these barriers.

FRONTIERS IN MEDICINE (2022)

Article Cell Biology

Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease

Danna Jennings et al.

Summary: Mutations in LRRK2 are common genetic risk factors for Parkinson's disease. Inhibition of LRRK2 with DNL201 has shown positive effects in preclinical and clinical trials, improving lysosomal function and demonstrating safety and tolerability. Further development of LRRK2 inhibitors as a therapeutic modality for Parkinson's disease is warranted.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Multidisciplinary Sciences

Structures of α-synuclein filaments from human brains with Lewy pathology

Yang Yang et al.

Summary: Parkinson's disease (PD) is a common movement disorder characterized by resting tremor, rigidity, bradykinesia and postural instability. It is associated with the presence of alpha-synuclein inclusions in brain cells. Many PD patients develop dementia after several years of diagnosis. PD dementia (PDD) is similar to dementia with Lewy bodies (DLB), which is diagnosed when cognitive impairment precedes parkinsonian motor signs or begins within one year from their onset.

NATURE (2022)

Article Multidisciplinary Sciences

The clinical drug candidate anle138b binds in a cavity of lipidic α-synuclein fibrils

Leif Antonschmidt et al.

Summary: Aggregation of amyloidogenic proteins is a characteristic of multiple neurodegenerative diseases. Investigating the interaction between these proteins and potential drugs is crucial for therapeutic development.

NATURE COMMUNICATIONS (2022)

Review Clinical Neurology

Evidence of distinct α-synuclein strains underlying disease heterogeneity

Sara A. M. Holec et al.

Summary: Synucleinopathies are neurodegenerative disorders caused by the misfolding of alpha-synuclein protein, with each disorder differing in various aspects. The strain hypothesis postulates that each synucleinopathy is caused by a unique alpha-synuclein structure. Different models have been established to evaluate the behavior of alpha-synuclein strains.

ACTA NEUROPATHOLOGICA (2021)

Article Endocrinology & Metabolism

In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET

Majken B. Thomsen et al.

Summary: The study evaluated the use of [11C]UCB-J PET as an in vivo biomarker of regional cerebral synaptic SV2A density in rat lesion models of neurodegeneration. Results showed that [11C]UCB-J PET provides a good in vivo marker of synaptic SV2A density and can be useful for monitoring the synaptic responses to potential neuroprotective agents over time in models of neurodegeneration.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

18F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging

Ryuichi Harada et al.

Summary: F-18-SMBT-1, a selective MAO-B PET tracer, showed high binding affinity to MAO-B with no toxic effects, making it a promising candidate for quantitative monitoring of astrogliosis in the human brain.

JOURNAL OF NUCLEAR MEDICINE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

First-in-Human Evaluation of 18F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A

Mika Naganawa et al.

Summary: The novel synaptic vesicle glycoprotein 2A tracer, F-18-SynVesT-1, displays excellent kinetic and in vivo binding properties in humans, showing great potential for imaging and quantification of synaptic density in neuropsychiatric disorders.

JOURNAL OF NUCLEAR MEDICINE (2021)

Article Biochemistry & Molecular Biology

PET Imaging of VMAT2 with the Novel Radioligand [18F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [11C]DTBZ and [18F]FE-DTBZ

Sangram Nag et al.

Summary: The study found that [F-18]FE-DTBZ-d4 has higher brain uptake and faster washout rate in nonhuman primate brains, showing better imaging properties and higher binding potential values compared to [C-11]DTBZ and [F-18]FE-DTBZ. Additionally, [F-18]FE-DTBZ-d4 exhibited faster radiometabolism in plasma, indicating increased stability against defluorination.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Novel Positron Emission Tomography Radiotracers for Imaging Mitochondrial Complex I

Yulong Xu et al.

Summary: This study found that the newly developed MC-I PET tracer F-18-2 showed rapid brain uptake and long-lasting binding in specific brain regions, indicating its potential for future studies on mitochondrial dysfunction in the central nervous system.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

[11C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates

Laura Kuebler et al.

Summary: The newly developed MODAG-001 PET tracer based on anle138b showed high affinity in vitro and good penetration and stability in the mouse brain. However, no detectable binding to aggregated alpha SYN was found in human brain sections of LBD cases, possibly due to low abundance of aggregated alpha SYN against background protein.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Clinical Neurology

From iPS Cells to Rodents and Nonhuman Primates: Filling Gaps in Modeling Parkinson's Disease

Tiago F. Outeiro et al.

Summary: Parkinson's disease is primarily characterized by movement disorders associated with the loss of dopaminergic neurons. However, it is now understood as a complex condition with multiple nonmotor features, involving various protein inclusions. Familial forms of PD have provided insights into the molecular pathways leading to neurodegeneration, adding complexity to the issue. Models using patient-derived cells and animal models, combined with current technological tools, are proposed to expand understanding and identify therapeutic strategies for PD.

MOVEMENT DISORDERS (2021)

Article Neurosciences

Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease

David J. Marmion et al.

Summary: Multiple system atrophy (MSA) is a progressive neurodegenerative disease with unclear pathogenesis. Studies using large animal models have successfully reproduced some pathological features of the disease.

NEUROBIOLOGY OF DISEASE (2021)

Article Clinical Neurology

Parkinson's disease outside the brain: targeting the autonomic nervous system

Yehonatan Sharabi et al.

Summary: Patients with Parkinson's disease may exhibit signs of dysregulation of the peripheral autonomic nervous system, which could serve as early biomarkers for the disease. Dysfunction of the autonomic nervous system may play a role in the spread of Parkinson's disease pathology, emphasizing the importance of developing early diagnostic tests and strategies to prevent neurodegeneration.

LANCET NEUROLOGY (2021)

Article Chemistry, Medicinal

Development and biological evaluation of[18F]FMN3PA & [18F] FMN3PU for leucine-rich repeat kinase 2 (LRRK2) in vivo PET imaging

Noeen Malik et al.

Summary: This study evaluated two radiolabeled kinase inhibitors for LRRK2 in biological assessments, demonstrating significant specific binding in vitro, with one of the compounds showing good brain uptake in vivo but fast brain clearance.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

18F-Labelled pyrrolopyrimidines reveal brain leucine-rich repeat kinase 2 expression implicated in Parkinson's disease

Xueyuan Chen et al.

Summary: F-18-labelled pyrrolopyrimidines were synthesized and evaluated as PET probes to determine LRRK2 expression in the brain. The compounds can reflect changes in LRRK2 expression in Parkinson's disease and are related to dopamine transporter expression.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Geriatrics & Gerontology

Monitoring of a progressive functional dopaminergic deficit in the A53T-AAV synuclein rats by combining 6-[18F]fluoro-L-m-tyrosine imaging and motor performances analysis

Guillaume Becker et al.

Summary: Using the A53T-AAV rat model, this study established a progressive model for monitoring alpha-synuclein pathology longitudinally, utilizing both the [F-18]FMT PET tracer and behavioral parameters, which have strong relevance for translational approaches.

NEUROBIOLOGY OF AGING (2021)

Article Neurosciences

In vivo imaging of synaptic density with [11C]UCB-J PET in two mouse models of neurodegenerative disease

Mengfei Xiong et al.

Summary: The study investigated synaptic density in transgenic mouse models of Alzheimer's disease and Parkinson's disease using [C-11]UCB-J PET, suggesting that the PET imaging reflects synaptic density in mouse models of neurodegeneration with large inter-subject variation. Additionally, the study proposed that the model-independent AUCbrain/blood ratio can be used to evaluate [C-11]UCB-J binding as an alternative to full pharmacokinetic modeling.

NEUROIMAGE (2021)

Article Biochemistry & Molecular Biology

Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeys

Yunlong Tao et al.

Summary: The degeneration of dopamine neurons in the midbrain is the underlying cause of Parkinson's disease. While fetal mesencephalic tissue transplantation can improve motor symptoms, the outcomes vary due to undefined and unstandardized donor tissues. Induced pluripotent stem cells offer a potential autologous transplantation therapy for PD, but its efficacy remains uncertain, especially in primates.

NATURE MEDICINE (2021)

Article Neurosciences

PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats

Majken B. Thomsen et al.

Summary: The study demonstrates that intrastriatal injection of a-syn fibrils induces progressive synaptic dysfunction and degeneration of dopamine terminals prior to cell death. PET imaging shows a gradual decrease in VMAT2 and SV2A binding in the ipsilateral striatum, while misfolded a-syn pathology spreads anatomically connected regions and becomes bilateral over time. The presence of MHCII positive ramified microglia indicates neuroinflammation in the injected striatum and substantia nigra.

NEUROBIOLOGY OF DISEASE (2021)

Article Multidisciplinary Sciences

Synthesis and pharmacokinetic characterisation of a fluorine-18 labelled brain shuttle peptide fusion dimeric affibody

Takahiro Morito et al.

Summary: Brain PET imaging using radiolabelled proteins is a promising approach for visualizing molecular targets in the brain, but faces challenges in pharmacokinetics and labelling methods. This study demonstrates the successful synthesis of a BBB-permeable affibody molecule radiolabelled with a unique fluorine-18 labelling method. The results suggest that small brain shuttle peptide-fused fluorine-18 labelled protein binders may have potential applications in brain molecular imaging.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity

Simone Bido et al.

Summary: Recent findings suggest that accumulation of alpha-synuclein in microglial cells can induce selective degeneration of dopaminergic neurons, leading to the development of a reactive, pro-inflammatory state and phagocytic exhaustion in microglia.

NATURE COMMUNICATIONS (2021)

Article Neurosciences

In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer's Brain Tissue

Ruiqing Ni et al.

Summary: The use of multi-imaging tracers revealed different regional pattern of changes in autopsy AD brain with respect to amyloid plaque pathology versus astrogliosis and microgliosis, showing certain positive correlations between them.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Clinical Neurology

Early atypical signs and insula hypometabolism predict survival in multiple system atrophy

Stephan Grimaldi et al.

Summary: In this retrospective study, predictors of survival in patients with Multiple System Atrophy (MSA) were investigated using clinical and brain F-18-FDG PET metabolic features. Poor prognostic factors included orthostatic hypotension, stridor, and glucose PET hypometabolism in the left insula, while time to diagnosis and use of selective serotonin reuptake inhibitor (SSRI) were identified as good prognostic factors. Developing a predictive risk score showed a significant difference in survival between low-risk and high-risk groups.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Article Clinical Neurology

Neuroprotection of Exendin-4 by Enhanced Autophagy in a Parkinsonian Rat Model of α-Synucleinopathy

Lu-Lu Bu et al.

Summary: The study demonstrates that exendin-4 treatment can alleviate behavioral deficits, dopaminergic degeneration, and pathological alpha-synuclein aggregation in a parkinsonian rat model of alpha-synucleinopathy through enhanced autophagy via inhibiting the PI3K/Akt/mTOR pathway. These findings suggest that exendin-4 may represent a promising disease-modifying treatment for Parkinson's disease.

NEUROTHERAPEUTICS (2021)

Article Neurosciences

Synaptic Density and Neuronal Metabolic Function Measured by Positron Emission Tomography in the Unilateral 6-OHDA Rat Model of Parkinson's Disease

Nakul Ravi Raval et al.

Summary: The study investigated [C-11]UCB-J binding and [F-18]FDG uptake in the CSTC circuit following a unilateral dopaminergic lesion in rats, showing lower binding and uptake in the ipsilateral striatal regions compared to the contralateral regions. Differential changes between hemispheres for [C-11]UCB-J and [F-18]FDG outcomes were evident, especially in cortical regions. The results suggest that combined [C-11]UCB-J and [F-18]FDG scans could provide a more comprehensive understanding of heterogeneous cerebral changes in neurodegenerative disorders.

FRONTIERS IN SYNAPTIC NEUROSCIENCE (2021)

Review Immunology

Towards PET imaging of the dynamic phenotypes of microglia

Wissam Beaino et al.

Summary: There is increasing evidence showing the heterogeneity of microglia activation in neuroinflammatory and neurodegenerative diseases. Pro-inflammatory microglia are believed to be detrimental while anti-inflammatory microglia may aid in damage repair. PET imaging shows potential for non-invasive quantification of neuroinflammation and discrimination between microglia phenotypes, but obstacles remain in targeting specific markers for selective imaging.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)

Article Neurosciences

[18F]FDG PET/CT Studies in Transgenic Hualpha-Syn (A53T) Parkinson's Disease Mouse Model of α-Synucleinopathy

Rommani Mondal et al.

Summary: The M83 transgenic mouse line is a model of alpha-synucleinopathy found in Parkinson's disease, useful for studying non-motor deficits in the early stages of PD. Research findings indicate metabolic changes and neurodegenerative symptoms in this PD mouse model, leading to progressive motor dysfunction and death. 9-month-old male and female Hualpha-Syn (A53) mice exhibit up to 30% decrease in [F-18]FDG uptake, consistent with cortical hypometabolism observed in PD patients.

FRONTIERS IN NEUROSCIENCE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Longitudinal PET Imaging of α7 Nicotinic Acetylcholine Receptors with [18F]ASEM in a Rat Model of Parkinson's Disease

Steven Vetel et al.

MOLECULAR IMAGING AND BIOLOGY (2020)

Review Radiology, Nuclear Medicine & Medical Imaging

Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development

Stuart P. McCluskey et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging SERT Availability in a Rat Model of L-DOPA-Induced Dyskinesia

Michael Walker et al.

MOLECULAR IMAGING AND BIOLOGY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of the Neuroprotective Effect of Microglial Depletion by CSF-1R Inhibition in a Parkinson's Animal Model

Se Jong Oh et al.

MOLECULAR IMAGING AND BIOLOGY (2020)

Article Multidisciplinary Sciences

Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy

Mohammad Shahnawaz et al.

NATURE (2020)

Review Clinical Neurology

LRRK2 in Parkinson disease: challenges of clinical trials

Eduardo Tolosa et al.

NATURE REVIEWS NEUROLOGY (2020)

Article Clinical Neurology

In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease

Tatsuhiro Terada et al.

NEUROLOGY (2020)

Article Multidisciplinary Sciences

The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration

Anne-Laure Mahul-Mellier et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

[18F]-DPA-714 PET as a specific in vivo marker of early microglial activation in a rat model of progressive dopaminergic degeneration

Tatiana Rodriguez-Chinchilla et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Confirmation of 123I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders

Daniela D. Maltais et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

Article Multidisciplinary Sciences

Structures of α-synuclein filaments from multiple system atrophy

Manuel Schweighauser et al.

NATURE (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers

Cristian C. Constantinescu et al.

MOLECULAR IMAGING AND BIOLOGY (2019)

Article Biochemistry & Molecular Biology

PET imaging of dopamine release in the frontal cortex of manganese-exposed non-human primates

Tomas R. Guilarte et al.

JOURNAL OF NEUROCHEMISTRY (2019)

Article Clinical Neurology

Oral and intravenous transmission of α-synuclein fibrils to mice

Stephanie Lohmann et al.

ACTA NEUROPATHOLOGICA (2019)

Article Multidisciplinary Sciences

Intestinal infection triggers Parkinson's disease-like symptoms in Pink1-/- mice

Diana Matheoud et al.

NATURE (2019)

Review Neurosciences

Believing in dopamine

Samuel J. Gershman et al.

NATURE REVIEWS NEUROSCIENCE (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Development of a novel radioligand for imaging 18-kD translocator protein (TSPO) in a rat model of Parkinson's disease

Chun-Yi Wu et al.

BMC MEDICAL IMAGING (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

PET imaging of [11C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding

Katarina Varnas et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

Review Neurosciences

Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis

Michaela E. Johnson et al.

TRENDS IN NEUROSCIENCES (2019)

Article Medicine, Research & Experimental

In Silico, in Vitro, and in Vivo Evaluation of New Candidates for α-Synuclein PET Imaging

Mathieu Verdurand et al.

MOLECULAR PHARMACEUTICS (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Cholinergic PET imaging in infections and inflammation using 11C-donepezil and 18F-FEOBV

Nis Pedersen Jorgensen et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)

Article Endocrinology & Metabolism

Brain energy metabolism and neuroinflammation in ageing APP/PS1-21 mice using longitudinal 18F-FDG and 18F-DPA-714 PET imaging

Jatta S. Takkinen et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Metabolic Imaging in Parkinson Disease

Sanne K. Meles et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys

Masakatsu Kanazawa et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Article Multidisciplinary Sciences

Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain

Poonam Thakur et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Neurosciences

Microglial phenotypes in Parkinson's disease and animal models of the disease

Valerie Joers et al.

PROGRESS IN NEUROBIOLOGY (2017)

Review Neurosciences

The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis

Heather D. E. Booth et al.

TRENDS IN NEUROSCIENCES (2017)

Article Multidisciplinary Sciences

Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease

Jenny-Ann Phan et al.

SCIENTIFIC REPORTS (2017)

Article Medicine, General & Internal

Parkinson disease

Werner Poewe et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Article Neurosciences

Propagation of pathological α-synuclein in marmoset brain

Aki Shimozawa et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)

Article Chemistry, Medicinal

Synthesis of [11C]HG-10-102-01 as a new potential PET agent for imaging of LRRK2 enzyme in Parkinson's disease

Min Wang et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice

Michael Walker et al.

JOURNAL OF NUCLEAR MEDICINE (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study

Matthias Brendel et al.

JOURNAL OF NUCLEAR MEDICINE (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

PET Imaging of Mitochondrial Complex I with 18F-BCPP-EF in the Brains of MPTP-Treated Monkeys

Hideo Tsukada et al.

JOURNAL OF NUCLEAR MEDICINE (2016)

Article Neurosciences

Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model

Renata P. Lerner et al.

NEUROBIOLOGY OF DISEASE (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

PET imaging of dopamine transporters with [18F]FE-PE2I: Effects of anti-Parkinsonian drugs

Ji-In Bang et al.

NUCLEAR MEDICINE AND BIOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study

Elena Rodriguez-Vieitez et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)

Article Geriatrics & Gerontology

Therapeutic potentials of human adipose-derived stem cells on the mouse model of Parkinson's disease

Hee Soon Choi et al.

NEUROBIOLOGY OF AGING (2015)

Review Clinical Neurology

Neuroimaging in Parkinson disease: from research setting to clinical practice

Marios Politis

NATURE REVIEWS NEUROLOGY (2014)

Article Cell & Tissue Engineering

PET Imaging of Serotonin Transporters With 4-[18F]-ADAM in a Parkinsonian Rat Model

Shao-Ju Weng et al.

CELL TRANSPLANTATION (2013)

Article Endocrinology & Metabolism

In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [F-18]FDOPA PET

Matthew D. Walker et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)

Article Endocrinology & Metabolism

Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism

Yilong Ma et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

In Vivo Dopamine Transporter Imaging in a Unilateral 6-Hydroxydopamine Rat Model of Parkinson Disease Using 11C-Methylphenidate PET

Vesna Sossi et al.

JOURNAL OF NUCLEAR MEDICINE (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

[18F]desmethoxyfallypride as a novel PET radiotracer for quantitative in vivo dopamine D2/D3 receptor imaging in rat models of neurodegenerative diseases

Mate D. Doebroessy et al.

NUCLEAR MEDICINE AND BIOLOGY (2012)

Article Biochemistry & Molecular Biology

E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment

Kristel L. Emmer et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Striatal adenosine A2A receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [18F]-MRS5425

Abesh Kumar Bhattacharjee et al.

NUCLEAR MEDICINE AND BIOLOGY (2011)

Article Biotechnology & Applied Microbiology

Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC

Piotr Hadaczek et al.

MOLECULAR THERAPY (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease

Julie L. Wang et al.

NUCLEAR MEDICINE AND BIOLOGY (2010)

Article Geriatrics & Gerontology

PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET

Sriram Venneti et al.

NEUROBIOLOGY OF AGING (2009)

Article Biochemistry & Molecular Biology

VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease

Ming-Kai Chen et al.

JOURNAL OF NEUROCHEMISTRY (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease

Cindy Casteels et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

Modulation of dopaminergic and glutamatergic brain function: PET studies on Parkinsonian rats

Daniela Pellegrino et al.

JOURNAL OF NUCLEAR MEDICINE (2007)

Article Endocrinology & Metabolism

Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility

Yilong Ma et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)

Article Biochemical Research Methods

Protocol for the MPTP mouse model of Parkinson's disease

Vernice Jackson-Lewis et al.

NATURE PROTOCOLS (2007)

Review Genetics & Heredity

Genetics of Parkinson disease: paradigm shifts and future prospects

MJ Farrer

NATURE REVIEWS GENETICS (2006)

Article Multidisciplinary Sciences

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

BA Lynch et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Letter Biotechnology & Applied Microbiology

In vivo PET imaging of gene expression in parkinsonian monkeys

JL Eberling et al.

MOLECULAR THERAPY (2003)

Article Multidisciplinary Sciences

Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53→Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice

MK Lee et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Neurosciences

Neuropathology in mice expressing human α-synuclein

H van der Putten et al.

JOURNAL OF NEUROSCIENCE (2000)